Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score a data driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
MyHealthChecked PLC ( (GB:MHC) ) has shared an announcement.
MyHealthChecked PLC has announced the registration of its phlebotomy test kits in the UK and EU, marking a significant step towards launching its phlebotomy service in the first half of 2025. This advancement is expected to expand the company’s product offerings beyond its existing at-home and rapid tests, potentially strengthening its position in the growing market for at-home healthcare solutions.
More about MyHealthChecked PLC
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted UK healthcare company specializing in at-home healthcare and wellness tests. The company offers a range of self-administered rapid tests and sample collection kits for DNA, RNA, and blood, which are analyzed in partner laboratories. These products are available online and over-the-counter, reflecting a shift towards accessible healthcare in the home testing kit market.
YTD Price Performance: 4.00%
Average Trading Volume: 36,458
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £6.76M
For an in-depth examination of MHC stock, go to TipRanks’ Stock Analysis page.
